ID: ALA1208929

Max Phase: Preclinical

Molecular Formula: C19H17NO2

Molecular Weight: 291.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(NCCc1ccc(O)cc1)c1ccc2ccccc2c1

Standard InChI:  InChI=1S/C19H17NO2/c21-18-9-5-14(6-10-18)11-12-20-19(22)17-8-7-15-3-1-2-4-16(15)13-17/h1-10,13,21H,11-12H2,(H,20,22)

Standard InChI Key:  GNICGVUADRUNFK-UHFFFAOYSA-N

Associated Targets(Human)

Dynamin-1 215 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 291.35Molecular Weight (Monoisotopic): 291.1259AlogP: 3.52#Rotatable Bonds: 4
Polar Surface Area: 49.33Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.50CX Basic pKa: CX LogP: 3.75CX LogD: 3.74
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.77Np Likeness Score: -0.47

References

1. Lee S, Jung KY, Park J, Cho JH, Kim YC, Chang S..  (2010)  Synthesis of potent chemical inhibitors of dynamin GTPase.,  20  (16): [PMID:20621477] [10.1016/j.bmcl.2010.06.092]

Source